Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:O15085 (
PDZ-RhoGEF
)
91
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Spinal cord injury (SCI) causes sensory dysfunctions such as
paresthesia
, dysesthesia, and chronic neuropathic pain. MiR-20a facilitates the axonal outgrowth of the cortical neurons. However, the role of miR-20a in the axonal outgrowth of primary sensory neurons and spinal cord dorsal column lesion (SDCL) is yet unknown. Therefore, the role of miR-20a post-SDCL was investigated in rat. The NF-200 immunofluorescence staining was applied to observe whether axonal outgrowth of dorsal root ganglion (DRG) neurons could be altered by miR-20a or
PDZ-RhoGEF
modulation in vitro. The expression of miR-20a was quantized with RT-PCR. Western blotting analyzed the expression of
PDZ-RhoGEF
/RhoA/GAP43 axis after miR-20a or
PDZ-RhoGEF
was modulated. The spinal cord sensory conduction function was assessed by somatosensory-evoked potentials and tape removal test. The results demonstrated that the expression of miR-20a decreased in a time-dependent manner post-SDCL. The regulation of miR-20a modulated the axonal growth and the expression of
PDZ-RhoGEF
/RhoA/GAP43 axis in vitro. The in vivo regulation of miR-20a altered the expression of miR-20a-
PDZ-RhoGEF
/RhoA/GAP43 axis and promoted the recovery of ascending sensory function post-SDCL. The results indicated that miR-20a/
PDZ-RhoGEF
/RhoA/GAP43 axis is associated with the pathophysiological process of SDCL. Thus, targeting the miR-20a/
PDZ-RhoGEF
/RhoA/GAP43 axis served as a novel strategy in promoting the sensory function recovery post-SCI.
...
PMID:MiR-20a Plays a Key Regulatory Role in the Repair of Spinal Cord Dorsal Column Lesion via PDZ-RhoGEF/RhoA/GAP43 Axis in Rat. 3042 36